Bank of Montreal
LUMO

Bank of Montreal’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bank of Montreal’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-219
Closed -$3K – 5040
2019
Q2 		$3K Buy
219
+6
+3% +$91 ﹤0.01% 4735
2019
Q1 		$4K Sell
213
-50
-19% -$745 ﹤0.01% 4073
2018
Q4 		$4K Sell
263
-1,982
-88% -$34.9K ﹤0.01% 4191
2018
Q3 		$48K Hold
2,245
– – ﹤0.01% 3415
2018
Q2 		$96K Buy
2,245
+23
+1% +$1.05K ﹤0.01% 3139
2018
Q1 		$145K Buy
2,222
+1,333
+150% +$94.4K ﹤0.01% 2788
2017
Q4 		$65K Sell
889
-6,440
-88% -$533K ﹤0.01% 3173
2017
Q3 		$672K Buy
7,329
+4,442
+154% +$341K ﹤0.01% 2143
2017
Q2 		$191K Buy
+2,887
New +$357K ﹤0.01% 2676
2016
Q2 		– Sell
-612
Closed -$100K – 4366
2016
Q1 		$100K Buy
612
+44
+8% +$8.92K ﹤0.01% 2792
2015
Q4 		$186K Sell
568
-203
-26% -$66.1K ﹤0.01% 2464
2015
Q3 		$248K Sell
771
-434
-36% -$191K ﹤0.01% 2158
2015
Q2 		$480K Buy
+1,205
New +$512K ﹤0.01% 1993
2014
Q4 		– Sell
-99
Closed -$19K – 4210
2014
Q3 		$19K Sell
99
-49
-33% -$10.8K ﹤0.01% 3483
2014
Q2 		$36K Buy
148
+49
+49% +$9.96K ﹤0.01% 3349
2014
Q1 		$25K Buy
99
+45
+83% +$13.8K ﹤0.01% 3414
2013
Q4 		$11K Hold
54
– – ﹤0.01% 3385
2013
Q3 		$9K Hold
54
– – ﹤0.01% 3462
2013
Q2 		$10K Buy
+54
New +$7.65K ﹤0.01% 3303

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal's LUMO Position: Q3 2019 in Review

Bank of Montreal sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2019, closing a stake of 219 shares — an estimated $3K sold.

Bank of Montreal first reported a position in LUMO in Q2 2013 and held it in 19 quarters. The position peaked at $672K in Q3 2017. 68 funds tracked by Wall St. Rank hold LUMO as of Q3 2019.

  • Bank of Montreal reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Bank of Montreal sold 219 Lumos Pharma, Inc. Common Stock shares in Q3 2019, an estimated $3K.
  • Bank of Montreal first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 19 quarters.
  • Bank of Montreal's Lumos Pharma, Inc. Common Stock position peaked at $672K in Q3 2017.
  • 68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2019.

Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.